INFLAMAX
Live / Registered — Registered (as of 21 Apr 2026)
What this means for you
Registered since 21 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 98642385
- Registration number
- 8218014
- Mark type
- Word mark
- Filed
- 10 Jul 2024
- Published for opposition
- 03 Mar 2026
- Registered
- 21 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 21 Apr 2032 (grace period to 21 Oct 2032)
- Attorney of record
- Frank W. Compagni
Goods and services
- Class 005 — Pharmaceuticals: Topical cream for pain and inflammation relief
Owner
- Xenex Laboratories Inc., Coquitlam, BC, CA
- Xenex Laboratories Inc., Coquitlam, BC, CA
- Xenex Laboratories Inc., Coquitlam, BC, CA
Prosecution history
- 21 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jan 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 24 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Jan 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 28 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 20 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 19 Feb 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 Feb 2025 — LETTER OF SUSPENSION E-MAILED
- 19 Feb 2025 — SUSPENSION LETTER WRITTEN